Abbott Laboratories Corporation

Rachael Buck

Geralyn O Duska-McEwen

Joseph P Schaller

Steven R Davis

Geralyn O Duska-Mcewen

JoMay Chow

Hawley K Linke

Maria Ramirez Gonzalez

Enrique Vazquez Hernandez

Debra Thomas

Ricardo Rueda Cabrera

Jomay Chow

Alejandro Barranco Perez

Paul Forsythe

Geralyn Duska-Mcewen

Debra L Thomas

Sharon Donovan

Sarah S Comstock

Alejandro Perez Barranco

Maria Gonzalez Ramirez

Enrique Hernandez Vazquez

Maria Ramirez Gonzales

Steven Davis

Disclosed are methods of reducing the incidence of necrotizing enterocolitis in an infant, toddler, or child using nutritional compositions including human milk oligosaccharides. The nutritional compositions including the human milk oligosaccharides are effective in reducing inflammation and the incidence of inflammatory diseases.

Methods for decreasing the incidence of necrotizing enterocolitis in infants, toddlers, or children using human milk oligosaccharides

Disclosed are nutritional compositions including human milk oligosaccharides that can be administered to preterm infants, term infants, toddlers, and children for improving airway defense mechanisms.

Methods of using human milk oligosaccharides for improving airway respiratory health

Disclosed are nutritional compositions including 2'-fucosyllactose (2′-FL) in combination with lutein and RRR-alpha-tocopherol. The nutritional compositions are useful for improving at least one of gut function, health, and development in an individual. In certain embodiments, the nutritional compositions can improve growth or maturation of the gut, as well as promote a healthy balance of beneficial bacteria in the gastrointestinal tract thereby treating and/or preventing formula intolerance or other gastrointestinal diseases and/or disorders resulting from suboptimal gastrointestinal flora population/balance.

Methods for increasing growth of beneficial bacteria in the gastrointestinal tract

Disclosed are nutritional compositions including human milk oligosaccharides in combination with long chain polyunsaturated fatty acids and/or carotenoids that can be administered to preterm infants, term infants, toddlers, and children for reducing inflammation and the incidence of inflammatory diseases.

Nutritional formulations including human milk oligosaccharides and antioxidants and uses thereof

Disclosed are nutritional compositions including human milk oligosaccharides and nucleotides that can be administered to preterm infants, term infants, toddlers, and children for reducing inflammation and the incidence of inflammatory diseases.

Nutritional compositions comprising human milk oligosaccharides and nucleotides and uses thereof for treating and/or preventing enteric viral infection

Disclosed are nutritional compositions including human milk oligosaccharides that can be administered to individuals including preterm infants, infants, toddlers, and children for improving gastrointestinal function and tolerance, as well as the growth of beneficial bacteria. Additional suitable methods of using the nutritional compositions including the human milk oligosaccharides are also disclosed.

Human milk oligosaccharides to promote growth of beneficial bacteria

Disclosed are methods of reducing the incidence of oxidative stress in infants, toddlers, and children using nutritional compositions including human milk oligosaccharides. The nutritional compositions including the human milk oligosaccharides are effective at reducing inflammation and the incidence of inflammatory diseases.

Methods for reducing the incidence of oxidative stress using human milk oligosaccharides, vitamin c and anti-inflammatory agents

Disclosed are nutritional compositions including 2'-fucosyllactose (2&#x2032;-FL) in combination with lutein and RRR-alpha-tocopherol. The nutritional compositions are useful for improving at least one of gut function, health, and development in an individual. In certain embodiments, the nutritional compositions can improve growth or maturation of the gut, as well as promote a healthy balance of beneficial bacteria in the gastrointestinal tract thereby treating and/or preventing formula intolerance or other gastrointestinal diseases and/or disorders resulting from suboptimal gastrointestinal flora population/balance.

Growing community of inventors

Gahanna, OH, United States of America

Rachael Buck